Blar i Department of Economics på tidsskrift "BMC Cancer"
Viser treff 1-1 av 1
-
How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review
(Journal article; Peer reviewed, 2021)Background Despite the increasing economic assessment of biomarker-guided therapies, no clear agreement exists whether existing methods are sufficient or whether different methods might produce different cost-effectiveness ...